Lyfstone® Calprotectin

In a prosthetic joint, the first priority is to reliably rule out infection.The Lyfstone® test is a CE-IVD labelled Point of Care test, which measures the amount of calprotectin in synovial fluid. Calprotectin is abundantly present in neutrophils. Presence of neutrophils is a hallmark of PJI, and a massive release of calprotectin occurs upon encounter with pathogens. Elevated levels of calprotectin are proven indicators of both acute and chronic PJI. 

To assess the risk of periprosthetic joint infection, a small amount of synovial fluid is extracted from the patient's joint. The Lyfstone® test requires only 20 μl and generates results in 15 minutes. The easy sample work-up allows implementation at any stage of care, from consulting to pre-op to per-op.

The efficiency of Lyfstone® Calprotectin test is clinically proven. In a prospective clinical study of 123 patients at a leading US Hospital system using the MSIS-13 criteria as comparator, the Lyfstone® Calprotectin test showed excellent sensitivity (98.1%) and specificity (95.7%). The calprotectin test outperformed blood-based PJI diagnostic tests such as CRP and ESR, confirming its diagnostic utility.

[Source: Diagnostic Utility of a Novel Point-of-Care Test of Calprotectin for Periprosthetic Joint Infection after Total Knee Arthroplasty: A Prospective Cohort Study.]

BE SURE. FASTER.

Learn more at www.lyfstone.com